About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials in Illinois | 14,943 Studies Near You | Clareo Health

Clinical Trials LocationsIllinois

Clinical Trials in Illinois

Discover 14,943 clinical trials near Illinois. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 10381-10400 of 14,943 trials

COMPLETEDNA9.3 miles

Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens

NCT01484028

This study will serve to evaluate and compare the performance of two new lenses to a marketed lens.

Refractive Ametropia

Johnson & Johnson Vision Care, Inc.275 participantsStarted Nov 2011

Mission Viejo, California, United States • Mission Viejo, California, United States • Pismo Beach, California, United States +12 more locations

COMPLETEDNA9.3 miles

Vistakon Investigational Multi-purpose Contact Lens Care Solution.

NCT01055457

This study compares an investigational contact lens care multi-purpose solution to a currently marketed multi-purpose solution.

Contact Lens Wear

Johnson & Johnson Vision Care, Inc.315 participantsStarted Nov 2009

Mission Viejo, California, United States • Orlando, Florida, United States • Tallahassee, Florida, United States +11 more locations

Find Trials by Condition in Illinois

Breast Cancerin Illinois Lung Cancerin Illinois Prostate Cancerin Illinois Colorectal Cancerin Illinois Melanomain Illinois Leukemiain Illinois Lymphomain Illinois Pancreatic Cancerin Illinois Ovarian Cancerin Illinois Brain Cancerin Illinois Diabetes

Data from ClinicalTrials.govTerms

COMPLETEDPhase 311 miles

Phase III Cat-PAD Study

NCT01620762

The purpose of this study is to compare the treatment effect of two treatment regimens of Cat-PAD vs placebo and to evaluates the treatment effect of Cat-PAD on symptoms, rescue medication usage and Quality of Life.

Rhinoconjunctivitis

Circassia Limited1,408 participantsStarted Oct 2012

Rolling Hills Estates, California, United States • Colorado Springs, Colorado, United States • Denver, Colorado, United States +115 more locations

COMPLETEDPhase 335 miles

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

NCT00002569

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without chemotherapy in treating patients who have anaplastic oligodendroglioma.

Brain and Central Nervous System Tumors

Radiation Therapy Oncology Group299 participantsStarted Jul 1994

Mobile, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +92 more locations

COMPLETEDPhase 340 miles

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

NCT02517021

NEPA-15-18 is a clinical study assessing safety of pro-netupitant and palonosetron, two antiemetic drugs, given with oral dexamethasone. The objective of the study is to evaluate if pro-netupitant and palonosetron are safe when administered to prevent nausea and vomiting after administration of repeated cycles of chemotherapy.

Chemotherapy-Induced Nausea and Vomiting

Helsinn Healthcare SA405 participantsStarted Nov 2015

Santa Monica, California, United States • Whittier, California, United States • Grand Junction, Colorado, United States +71 more locations

COMPLETEDNA51 miles

VenaSeal Sapheon Closure System Pivotal Study (VeClose)

NCT01807585

The VeClose pivotal study was a controlled, randomized, prospective, multicenter, pivotal study in which patients with venous reflux in the great saphenous vein (GSV) were treated with either the VenaSeal closure system (VenaSeal SCS) or radiofrequency ablation (RFA) therapy.

Great Saphenous Vein (GSV) With Venous Reflux Disease

Medtronic Endovascular242 participantsStarted Mar 2013

Scottsdale, Arizona, United States • San Diego, California, United States • Greenwood Village, Colorado, United States +7 more locations

COMPLETEDPhase 2125 miles

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

NCT01985126

The purpose of this study is to evaluate the efficacy and safety of 2 daratumumab treatment regimens in participants with multiple myeloma who have received at least 3 prior lines of therapy (including a proteasome inhibitor \[PI\] and immunomodulatory drug \[IMiD\]) or are double refractory to a PI and an IMiD.

Multiple Myeloma

Janssen Research & Development, LLC124 participantsStarted Sep 2013

Duarte, California, United States • Los Angeles, California, United States • Atlanta, Georgia, United States +20 more locations

COMPLETEDNA125 miles

Acute Study to Collect Electrical Signals From the Heart Using a Special Lead

NCT02772380

The main purpose of this clinical study is to collect electrograms from an investigational lead placed in an extravascular space, for development of a future Implantable Cardioverter Defibrillator (ICD) system.

TachycardiaVentricular Arrhythmias

Medtronic Cardiac Rhythm and Heart Failure87 participantsStarted May 2016

Scottsdale, Arizona, United States • Hartford, Connecticut, United States • Jacksonville, Florida, United States +33 more locations

COMPLETEDPhase 4135 miles

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

NCT01916226

This phase IV investigational trial is being conducted to evaluate the efficacy of a 2-week treatment of fluticasone propionate nasal spray (FPNS) vs. cetirizine on allergic nasal and ocular symptoms and quality of life in adult subjects with SAR. It is hypothesized that FPNS provides greater nasal symptom relief than cetirizine. The primary measure used to test this hypothesis is the change from baseline over two weeks in reflective total nasal symptom score (rTNSS) compared between FPNS and cetirizine. Approximately 648 subjects will be randomized into a 1:1:1:1 ratio of treatment allocation across approximately twenty-five to thirty-five sites in the US during the 2013 fall allergy season. All subjects will be outpatients. The total duration of study will be approximately 21 days including 7 days of screening period, and 14 days of treatment period.

Rhinitis, Allergic, Perennial and Seasonal

GlaxoSmithKline682 participantsStarted Aug 2013

Little Rock, Arkansas, United States • Denver, Colorado, United States • Aventura, Florida, United States +28 more locations

TERMINATEDPhase 3135 miles

A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

NCT02041091

The purpose of this study is to evaluate the amount of tabalumab in the blood after it is given by two different injection methods - A traditional syringe or a spring loaded syringe for 12 weeks. Participants may continue to receive study drug for up to 52 weeks.

Lupus Erythematosus, Systemic

Eli Lilly and Company226 participantsStarted Jan 2014

Covina, California, United States • El Cajon, California, United States • Long Beach, California, United States +41 more locations

COMPLETEDPhase 2189 miles

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

NCT00006358

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Thalidomide may stop the growth of cancer by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of combining temozolomide and thalidomide in treating patients who have recurrent or progressive brain tumor.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins44 participantsStarted Jun 2000

Los Angeles, California, United States • San Francisco, California, United States • Bethesda, Maryland, United States +8 more locations

COMPLETEDNA245 miles

Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients

NCT01016652

The purpose of this study is to evaluate the effect of a multi-focal contact lens on symptomatic patients.

Johnson & Johnson Vision Care, Inc.49 participantsStarted Oct 2009

North Little Rock, Arkansas, United States • Blue Springs, Missouri, United States • Lake Ozark, Missouri, United States +5 more locations

COMPLETEDPhase 2252 miles

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

NCT02583919

The purpose of this study is to evaluate the efficacy, safety, and tolerability of ISIS-GCGRRx in combination with metformin versus placebo

Type 2 Diabetes

Ionis Pharmaceuticals, Inc.79 participantsStarted Sep 2015

Greenbrae, California, United States • Huntington Park, California, United States • La Mesa, California, United States +16 more locations

COMPLETEDNA296 miles

Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear

NCT01669629

This is a one week 2x2 crossover study comparing delefilcon A with etafilcon A, with a primary hypothesis of comparing the handling of each lens. Additional secondary markers are measured looking at subjective comfort and vision of the lenses.

Johnson & Johnson Vision Care, Inc.183 participantsStarted Aug 2012

Little Rock, Arkansas, United States • Bridgeport, Connecticut, United States • Tampa, Florida, United States +7 more locations

COMPLETEDNA303 miles

Non-Invasive Neurostimulation for the Prevention of Chronic Migraine

NCT01667250

The purpose of this multi-center, prospective, double-blind, randomized, sham-controlled pilot study is to study feasibility and collect preliminary clinical data related to the safety and clinical benefits of daily use of non-invasive vagal nerve stimulation with the GammaCore device for the prevention of chronic migraine, and to support the development and approval of a larger pivotal study.

Chronic Migraine

ElectroCore INC59 participantsStarted Oct 2012

San Francisco, California, United States • Ann Arbor, Michigan, United States • Springfield, Missouri, United States +3 more locations

COMPLETEDNA317 miles

Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens

NCT01484054

To evaluate and compare the performance of a new contact lens to a marketed contact lens.

Refractive Ametropia

Johnson & Johnson Vision Care, Inc.103 participantsStarted Nov 2011

Bloomfield, Connecticut, United States • Tallahassee, Florida, United States • Overland Park, Kansas, United States +3 more locations

COMPLETED337 miles

COOL-ARREST Pilot Study to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest

NCT01818388

A multicenter prospective single arm interventional trial in hospitals where therapeutic hypothermia is standard practice. This trial will enroll 50 subjects to evaluate the ability of the ZOLL Intravascular Temperature Management (IVTM) System to induce, maintain, and reverse mild therapeutic hypothermia and maintain normothermia post cardiac arrest.

Out of Hospital Cardiac Arrest

ZOLL Circulation, Inc., USA50 participantsStarted Jul 2014

New Britain, Connecticut, United States • Detroit, Michigan, United States • Royal Oak, Michigan, United States +6 more locations

COMPLETEDNA527 miles

Pilot Evaluation of a New Galyfilcon A Lens Prototype and Enfilcon A Lens

NCT01192542

The purpose of this study is to compare the visual acuity, limbal and bulbar redness of the new galyfilcon A prototype lenses against Avaira® lenses when worn as daily wear for seven (7) days.

Johnson & Johnson Vision Care, Inc.39 participantsStarted Aug 2010

Pismo Beach, California, United States • Warwick, Rhode Island, United States • Fincastle, Virginia, United States

COMPLETEDPhase 1766 miles

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age

NCT01659086

The purpose of this study is to evaluate the safety, reactogenicity, and immunogenicity of different formulations of a two-dose primary series and booster vaccination of monovalent Influenza H9N2 vaccine manufactured in Quebec, Canada with and without adjuvant, in adults 18 to 64 years of age.

GlaxoSmithKline422 participantsStarted Aug 2012

Miami, Florida, United States • Edison, New Jersey, United States • Austin, Texas, United States +1 more locations

COMPLETEDNA786 miles

Evaluation of Etafilcon A Daily Disposable Lenses

NCT02061592

To evaluate the clinical performance of daily disposable etafilcon A lenses.

Johnson & Johnson Vision Care, Inc.136 participantsStarted Jan 2014

Jacksonville, Florida, United States • Honolulu, Hawaii, United States • Kahului, Hawaii, United States +4 more locations

PreviousPage 520 of 748Next

in Illinois

Heart Diseasein Illinois